1Fukuda Y,Mochimaru H,Terasaki Y,et al.Mechanism of structural remodeling in pulmonary fibrosis. Chest, 2001,120 ( Suppl 1 ) : 41-43.
2John AT, Vitor S, Catherine JW. The in vivo and vitro protective properties of taurine. Gen Pharmacol, 1995,26 : 453-462.
3Huxtable RJ. Physiological actions of taurine. Physiol Rev, 1992, 72:101-163.
4Birdsall TC. Therapeutic applications of taurine. Altern Med Bey, 1998,3 : 128-136.
5Kendler BS. Taurine: an overview of its role in preventive medicine. Prev Med,1989,18:79-100.
6Wang Q,Giri SN, Hyde DM, et al. Effects of taurine on bleomycin-induced lung fibrosis in hamster. Proc Soc Exp Biol Med,1989,190:330-338.
7Wang Q, Hyde DM, Giri SN. Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with tanrine and niacin.Lab Invest, 1992,67: 234-242.
8Gordon RE, Shaked AA, Solano DF. Taurine protects hamster bronchioles from acute NO2-induced alterations. A histologic, uhrastructural,and freeze-fracture study.Am J Pathol,1986,125:585-600.
9Wang J, Giri SN, Hyde DM, et al. Amelioration of bleomycin-induced pulmonary fibrosis in hamster by combined treatment with taurine and niacin. Biochem Pharmacol, 1991,42:1115-1122.
10Wang Q, Hollinger MA, Giri SN. Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment. J Pharmacol Exp Ther, 1992,262:127-132.
